INVESTOR READINESS, GENEVA
We get life sciences companies ready for diligence.
Swiss life-sciences advisory. Before your next round, we run the diligence your investor will run.
-
THE PROBLEM
Investors rarely say no. They say “not yet”.
-
THE COST
“Not yet” costs you runway.
-
OUR ANSWER
We find the gaps before investors do, so you can close them first.
HOW INVESTORS DECIDE
Investors don't buy your science. They price your risk.
Every question in diligence is the same question: what could go wrong, and do you know it before they do?
METHOD
Every investor runs diligence. Ours comes first.
01
Map
The diligence your next investor will run, at the bar of that round.
02
Fix
We fix what breaks, in the order that moves valuation.
03
Prove
A data room that answers before they ask.
SERVICES
Six services, one entry point
SERVICE 01 · THE ENTRY POINT
Readiness diligence
What will the next investor find, and what has to change first?
You receive: Assessment, ranked gaps, remediation plan
Scope and deliverablesRemediation plan
What to fix, in what order, and who does it. The plan becomes the proposal.
02
Data room
Can every diligence request be answered from a document?
03
Market and competitive analysis
How large is the opportunity, and who else is going after it?
04
Fractional CFO
Is the money buying milestones?
05
Fractional CMO
Will the development plan carry the company to its next milestone?
06
Board support
Does the board have what it needs to decide?
YOUR DOSSIER: NOT YET WRITTEN
Start with our diligence, before your next investor runs theirs.
Please send nothing confidential. If we go further, we sign an NDA before you share more.